Dr. Peter Attia, MD

Clinical Focus

Dr. Attia focuses on the applied science of longevity, which he frames as 'Medicine 3.0'. His practice emphasizes aggressive early intervention across four main pillars: nutritional biochemistry, exercise physiology, sleep physiology, and pharmacology/lipidology.

A core tenet of his practice is moving away from the standard model of treating diseases post-diagnosis, towards a preventative model targeting the root causes of the four major killers: heart disease, cancer, neurodegenerative disease, and metabolic disease.

Prescribing Patterns (Verified)

• ApoB Targeting Aggressive use of statins, ezetimibe, and PCSK9 inhibitors to drive ApoB to physiologic minimums (often <20-30 mg/dL).
• Rapamycin (Off-label) Prescribes pulsed dosing of Rapamycin for geroprotection based on individual risk tolerance and lab monitoring.
• Metabolic Management Utilization of SGLT2 inhibitors and metformin in specific, indicated patient populations.